This comprehensive GWAS reveals 15 new genetic variants linked to celiac disease, offering insights for earlier detection and ...

AI may provide an answer to the question of whether drugs initially developed and prescribed for non-neurodegenerative physical conditions can be used to treat individuals with Parkinson’s disease.

At LinkedIn India, Nithya Rajagopalan is helping shape a future where women lead — with intention, support, and a culture ...

Despite growing awareness and legislation mandating genotype testing before marriages, fake genotype results is on the rise.

Swiss start-up Haya Therapeutics has formed a partnership with Eli Lilly – worth up to $1 billion – to look for new therapies for obesity in non-coding DNA. The biotech focuses on trawling the ...

Not all DNA looks like the familiar twisted ladder. Sometimes, parts of our genetic code fold into unusual shapes. One such ...

Disrupting the G-loop cycle causes transcriptome dysregulation and genome instability, revealing key role in cell survival ...

For example, balancing selection is expected to ... and was overshadowed by the more-prominent controversy over whether protein and DNA sequence variation is explained by selection or by random ...

Inhibitors of DNA methylation can reactivate genes that have been silenced. Two examples of these types of drugs are 5-azacytidine and 5-aza-2′-deoxycytidine (Egger et al., 2004). These ...

the pharma group announced a $1 billion alliance with Swiss start-up Haya Therapeutics to hunt for new therapies for obesity and related metabolic disorders like diabetes in non-coding DNA ...

Hepatocellular carcinoma is the most frequent form of primary liver cancer, and most patients are diagnosed when the disease is already advanced and therefore prognosis is poor despite available ...

The Festival of Genomics and Biodata is just around the corner, and we’ve had the opportunity to sit down with […] ...